Compare Lustrum:ROHTO PHARMACEUTICAL CO.,LTD.:4527

※The values of financial statements might be different from the actual ones. Please confirm the original. [instructions]

Main FunctionHelp Company NameHelp CodeHelp Types of IndustryHelp Market Name Fiscal Year End Year of Listing
Browse U-Chart Add to 'Companies Comparison' list Compare Lustrum Ullet index ROHTO PHARMACEUTICAL CO.,LTD. Go to web site 4527 Medicals 東証プライム March 1, 2000 1961.
Analysis u.gifU-Chart AnalysisHelp hikaku.gifAdd to 'Companies Comparison' listHelp u2.gifCompare LustrumHelp mark.gifUllet indexHelp
Accounts Information Balance Sheet Profit and Loss Account Cash Flow Statement
Display

ROHTO PHARMACEUTICAL CO.,LTD. Balance Sheet(B/S)

[Show - Hide] U-Chart:Balance Sheet (B/S)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

ROHTO PHARMACEUTICAL CO.,LTD. Balance Sheet 2023年3月期 ROHTO PHARMACEUTICAL CO.,LTD. Balance Sheet 2022年3月期 ROHTO PHARMACEUTICAL CO.,LTD. Balance Sheet 2021年3月期 ROHTO PHARMACEUTICAL CO.,LTD. Balance Sheet 2020年3月期 ROHTO PHARMACEUTICAL CO.,LTD. Balance Sheet 2019年3月期

[Show - Hide] Balance Sheet (B/S)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020 March 31, 2019
Cash and Cash Equivalents
(Percent)
79,951up
(25.8%)down
72,791up
(26.5%)up
52,964up
(23.4%)up
45,307up
(21.0%)up
37,856
(18.8%)
Other Current AssetsHelp
(Percent)
110,295up
(35.6%)up
91,515up
(33.3%)down
80,107down
(35.4%)down
85,399up
(39.6%)up
78,546
(39.1%)
Tangible Fixed AssetsHelp
(Percent)
66,182up
(21.4%)down
62,839up
(22.9%)up
49,790up
(22.0%)down
48,539up
(22.5%)down
47,421
(23.6%)
Intangible Fixed AssetHelp
(Percent)
6,997up
(2.3%)down
6,587up
(2.4%)up
4,590up
(2.0%)up
2,685up
(1.2%)up
2,482
(1.2%)
Investments and OthersHelp
(Percent)
43,688up
(14.1%)up
38,190up
(13.9%)down
35,394up
(15.7%)up
31,269down
(14.5%)down
33,565
(16.7%)
Total AssetsHelp
(Percent)
309,677
(100%)
274,876
(100%)
226,149
(100%)
215,644
(100%)
200,953
(100%)
Total Current LiabilitiesHelp
(Percent)
92,591up
(29.9%)down
83,126up
(30.2%)up
64,454down
(28.5%)down
71,171up
(33.0%)down
68,198
(33.9%)
Total Long-term LiabilitiesHelp
(Percent)
7,516down
(2.4%)down
13,350up
(4.9%)up
5,787up
(2.6%)up
5,190up
(2.4%)up
1,483
(0.7%)
Shareholder's EquityHelp
(Percent)
209,570up
(67.7%)up
178,400up
(64.9%)down
155,908up
(68.9%)up
139,283up
(64.6%)down
131,272
(65.3%)
Total LiabilitiesHelp
(Percent)
309,677
(100%)
274,876
(100%)
226,149
(100%)
215,644
(100%)
200,953
(100%)

ROHTO PHARMACEUTICAL CO.,LTD. Profit and Loss Account(P/L)

[表示非表示] U-Chart:Profit and Loss Account (P/L)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

ROHTO PHARMACEUTICAL CO.,LTD. Profit and Loss Account 2023年3月期 ROHTO PHARMACEUTICAL CO.,LTD. Profit and Loss Account 2022年3月期 ROHTO PHARMACEUTICAL CO.,LTD. Profit and Loss Account 2021年3月期 ROHTO PHARMACEUTICAL CO.,LTD. Profit and Loss Account 2020年3月期 ROHTO PHARMACEUTICAL CO.,LTD. Profit and Loss Account 2019年3月期

[Show - Hide] Profit and Loss Account (P/L)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020 March 31, 2019
Amount of Sales
(Percent)
238,664
(100%)
199,646
(100%)
181,287
(100%)
188,327
(100%)
183,582
(100%)
Total Sales
(Percent)
238,664
(100%)
199,646
(100%)
181,287
(100%)
188,327
(100%)
183,582
(100%)
Cost of SalesHelp
(Percent)
101,243up
(42.4%)up
83,476up
(41.8%)up
74,326up
(41.0%)up
74,135up
(39.4%)down
74,048
(40.3%)
Other Costs and RevenueHelp 111,043up
(46.5%)down
95,042up
(47.6%)down
90,218down
(49.8%)down
98,783down
(52.5%)down
99,733
(54.3%)
Total CostsHelp 212,286 178,518 164,544 172,918 173,781
Net RevenueHelp 137,421up
(57.6%)down
116,170up
(58.2%)down
106,961down
(59.0%)down
114,192up
(60.6%)up
109,534
(59.7%)
Earnings Before TaxHelp 34,290up
(14.4%)up
27,874up
(14.0%)up
23,006up
(12.7%)up
21,730up
(11.5%)up
16,300
(8.9%)
Net IncomeHelp 26,378up
(11.1%)up
21,128up
(10.6%)up
16,743up
(9.2%)up
15,409up
(8.2%)up
9,801
(5.3%)
当期純利益 26,378 21,128 16,743 15,409 9,801

ROHTO PHARMACEUTICAL CO.,LTD. Cash Flow Statement(C/F)

[表示非表示] U-Chart:Cash Flow Statement (C/F)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

ROHTO PHARMACEUTICAL CO.,LTD. Cash Flow Statement 2023年3月期 ROHTO PHARMACEUTICAL CO.,LTD. Cash Flow Statement 2022年3月期 ROHTO PHARMACEUTICAL CO.,LTD. Cash Flow Statement 2021年3月期 ROHTO PHARMACEUTICAL CO.,LTD. Cash Flow Statement 2020年3月期 ROHTO PHARMACEUTICAL CO.,LTD. Cash Flow Statement 2019年3月期

[Show - Hide] Cash Flow Statement (C/F)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020 March 31, 2019
Operating Cash Flow(OFC)Help
(Percent)
30,925up
(85.5%)up
27,251up
(77.7%)down
20,077up
(99.5%)down
19,109down
(100.0%)
21,744
(100.0%)
Investing Cash Flow(ICF)Help
(Percent)
-13,176up
(-36.4%)up
-16,406down
(-46.8%)up
-10,237down
(-50.7%)down
-9,405up
(-49.2%)down
-10,245
(-47.1%)
Financing Cash FlowHelp
(Percent)
-16,199down
(-44.8%)down
3,470up
(9.9%)up
-2,347down
(-11.6%)down
-1,603up
(-8.4%)up
-3,386
(-15.6%)
Exchange Difference of Cash and Cash EquivalentsHelp
(Percent)
5,236up
(14.5%)up
4,335up
(12.4%)up
96up
(0.5%)up
-781up
(-4.1%)down
-832
(-3.8%)
Net Increase and Decrease in Cash and Cash Equivalentsn 6,786down
(18.8%)down
18,650up
(53.2%)up
7,589up
(37.6%)down
7,320up
(38.3%)up
7,281
(33.5%)

他社比較Help

Companies in 'Companies Comparison' list

Browsing historyHelp

Your reecently viewed companies

ROHTO PHARMACEUTICAL CO.,LTD.

Company where related level is highHelp

Sanko Junyaku Co.,Ltd.
TAISHO PHARMACEUTICAL CO.,LTD.
Oncolys BioPharma Inc.
Cuorips Inc.
BrightPath Biotherapeutics Co., Ltd.
SymBio Pharmaceuticals Limited
Sumitomo Pharma Co., Ltd.
ROHTO PHARMACEUTICAL CO.,LTD.
ECI,Inc.
DAIICHI SANKYO COMPANY, LIMITED